{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-037618","form_type":"8-K","ticker":"AMRN","cik":"0000897448","company_name":"AMARIN CORP PLCUK","filed_at":"2025-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.734893+00:00","generated_at":"2026-05-24T23:02:28.512123+00:00","sec_items":["2.02","3.03","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Amarin Q4 revenue $62.3M, net loss $48.6M; announces 1-for-20 ADS reverse split to maintain listing","bullets":["Q4 total net revenue $62.3M, down 17% YoY; net loss $48.6M vs $5.8M loss in Q4 2023.","U.S. VASCEPA revenue fell to $44.2M from $64.9M on generic competition; European revenue rose to $4.0M, RoW to $11.9M.","Cash and investments $294.2M at Dec 31, 2024, down from $320.7M a year earlier; no debt.","Announces 1-for-20 ADS reverse split effective ~April 11, 2025 to comply with Nasdaq $1 minimum bid price.","Non-GAAP adjusted net loss $8.7M ($0.02/ADS) vs adjusted loss $0.9M in Q4 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-037618","json":"https://secwatch.observer/filing/0000950170-25-037618.json","markdown":"https://secwatch.observer/filing/0000950170-25-037618.md","text":"https://secwatch.observer/filing/0000950170-25-037618.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/897448/000095017025037618/0000950170-25-037618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/897448/000095017025037618/amrn-20250312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T23:02:28.512123+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}